Clavam 625mg (Co-Amoxiclav) – San Diego, California, USA (2026)
Visit
Website: unnatipharmax.com
Phone: +91 82650 41513
Email: Unnatipharmax@gmail.com
PRODUCT NAME
Brand Name: Clavam 625mg
Generic Name: Co-Amoxiclav (Amoxicillin 500 mg + Clavulanic Acid 125 mg)
Strength: 625 mg
Dosage Form: Tablets
Therapeutic Category: Penicillin Antibiotic with Beta-Lactamase Inhibitor
PRODUCT DETAILS
Clavam 625mg contains Amoxicillin 500 mg and Clavulanic Acid 125 mg, a broad-spectrum combination antibiotic used to treat susceptible bacterial infections. Clavulanic acid inhibits beta-lactamase enzymes produced by certain bacteria, helping extend the antibacterial activity of amoxicillin.
It may be prescribed for susceptible bacterial infections such as:
- Respiratory tract infections
- Acute bacterial sinusitis
- Ear infections (otitis media)
- Urinary tract infections (UTIs)
- Skin and soft tissue infections
- Dental infections
- Other bacterial infections as determined by a healthcare professional
Clavam 625mg should be used only under medical supervision and is not effective against viral infections such as colds or influenza.
PRODUCT SPECIFICATION
| Brand Name | Clavam 625mg |
| Generic Name | Co-Amoxiclav (Amoxicillin + Clavulanic Acid) |
| Strength | 500 mg + 125 mg |
| Dosage Form | Tablet |
| Route | Oral |
| Therapeutic Class | Penicillin Antibiotic + Beta-Lactamase Inhibitor |
| Packaging | Blister Pack |
| Storage | Store below 25°C in a cool, dry place |
| Prescription | Required |
| Manufactured In | India |
| Export Availability | Worldwide (where legally permitted) |
KEY FEATURES
- Contains Amoxicillin 500 mg and Clavulanic Acid 125 mg
- Broad-spectrum antibiotic combination for susceptible bacterial infections
- Helps overcome certain beta-lactamase-producing bacteria
- Oral tablet formulation
- Manufactured in WHO-GMP compliant facilities
- Quality-assured pharmaceutical product
- Secure packaging for international export
- Available for retail, wholesale, and bulk supply
- Competitive export pricing
- Worldwide shipping where legally permitted
INDUSTRY UPDATE
The global market for combination antibiotics continues to evolve in 2026 with a strong emphasis on antimicrobial stewardship, responsible prescribing, and combating antimicrobial resistance (AMR). Co-Amoxiclav remains an important treatment option for selected bacterial infections when prescribed according to evidence-based clinical guidelines.
Key industry trends include:
- Increased focus on culture-guided antibiotic selection where appropriate
- Continued monitoring of antimicrobial resistance patterns worldwide
- Growing demand for high-quality generic antibiotics in regulated international markets
- Expansion of pharmaceutical quality assurance and regulatory compliance
- Ongoing investment in reliable global medicine supply chains and international pharmaceutical exports to improve access to essential medicines
San Diego's UC San Diego Health, Scripps Health, Sharp Healthcare, and Naval Medical Center San Diego manage bacterial infections for America's eighth-largest city — including the largest military concentration of any US city, a massive Mexican-American community in Logan Heights and National City, and San Diego's thriving biotech corridor workforce. San Diego's position on the US-Mexico border creates unique infection patterns from cross-border travel. Clavam 625mg provides San Diego's diverse population with affordable Co-Amoxiclav at dramatically reduced cost versus California pharmacy pricing.
Visit unnatipharmax.com | 📱 +91 82650 41513 | 📧 Unnatipharmax@gmail.com
FAQ 1: How does San Diego's US-Mexico border proximity create unique antibiotic resistance patterns requiring Clavam 625mg's Beta-lactamase coverage?
San Diego sits at one of the world's busiest international border crossings — the San Ysidro Port of Entry processes 70,000+ vehicle crossings and 20,000+ pedestrian crossings daily between San Diego and Tijuana. This extraordinary cross-border population movement creates a microbial ecology where antibiotic resistance patterns from Mexico's clinical environment directly influence San Diego's community bacterial resistance. Mexico's antibiotic resistance context: antibiotics have historically been available OTC in Mexican pharmacies without prescription — Amoxicillin, Ampicillin, and increasingly broader-spectrum antibiotics are purchased at Tijuana farmacias by both Mexican residents and Californians crossing the border; this OTC availability has driven higher community selection pressure for Beta-lactamase-producing bacteria in Baja California's clinical environment. The San Diego consequence: UC San Diego Health's clinical microbiology laboratory documents Beta-lactamase-producing E. coli and H. influenzae rates in San Diego ZIP codes bordering Mexico (National City, Chula Vista, Otay Mesa) that are significantly higher than San Diego's inland ZIP codes — directly influencing UCSD's antimicrobial prescribing guidance. Clavam 625mg's specific advantage: the Clavulanic Acid component inhibits the Beta-lactamase enzymes produced by these border-region bacteria — making Clavam 625mg (Co-Amoxiclav) the appropriate first-line choice for San Diego's border-adjacent communities where plain Amoxicillin would fail a significant proportion of cases. UCSD's border health programme: UC San Diego Center for Emerging Infectious Diseases (CEID) specifically studies cross-border antibiotic resistance transmission — informing UCSD's antimicrobial stewardship guidelines for San Diego's border-region patient populations and guiding Clavam 625mg's role in first-line border-region infection management.
FAQ 2: How does San Diego's massive military population — the largest in any US city — create specific Clavam 625mg demand?
San Diego hosts the US Pacific Fleet's largest concentration of naval assets — Naval Air Station North Island, Marine Corps Air Station Miramar, Camp Pendleton (the Marine Corps' largest West Coast base), and Naval Medical Center San Diego (NMCSD) collectively support approximately 100,000 active-duty military personnel and an equivalent number of dependents in the San Diego metro area. Military community infection patterns requiring Clavam: combat wound infections — Marines returning from deployments with wound infections may carry antibiotic-resistant organisms from deployment environments (Afghanistan, Middle East, and now Indo-Pacific training environments); these wound infections require Beta-lactamase-stable coverage where Clavam 625mg (outpatient) or IV Piperacillin-Tazobactam (inpatient equivalent) is appropriate. Human and animal bite wound infections: Camp Pendleton's working dog programme and San Diego's large pet-owning military family population creates dog bite wound infections — Pasteurella multocida (from dog/cat bites) and Capnocytophaga canimorsus (from dog bites) are reliably covered by Clavam 625mg as first-line bite wound antibiotic therapy. Military dental care access: NMCSD's dental clinics manage dental infections for active-duty San Diego personnel — dental abscess with spreading cellulitis (Ludwig's angina risk) requires Clavam 625mg or amoxicillin plus Metronidazole depending on severity. Transitioning veterans losing TRICARE: San Diego has one of America's largest veteran populations — veterans who lose TRICARE coverage after separation and are in the VA waiting period access civilian healthcare where Clavam 625mg at standard California pharmacy pricing creates cost barriers; Clavam 625mg from Unnati Pharmax at dramatically reduced cost specifically serves San Diego's transitioning veterans in TRICARE-to-VA coverage gaps.
FAQ 3: How does California's Medi-Cal coverage address Clavam 625mg for San Diego's large uninsured and undocumented community?
California's Medi-Cal — after the historic 2023-2024 expansion to income-eligible adults regardless of immigration status — covers approximately 14.5 million Californians. In San Diego, this expansion has brought Medi-Cal coverage to tens of thousands of previously uninsured undocumented residents, including the large communities in National City, Chula Vista, and Barrio Logan. Medi-Cal and Clavam 625mg: California Medi-Cal covers Co-Amoxiclav (Augmentin generic) on its formulary for appropriate bacterial infection indications; prescriptions for Medi-Cal-enrolled patients are dispensed at negligible patient cost at California pharmacies. The remaining coverage gaps in San Diego: new Medi-Cal enrollees in the administrative processing period (6-12 weeks from application to active coverage) — California's DHS processes Medi-Cal applications within 45 days but many San Diegans experience delays in the physical card issuance and pharmacy activation; and San Diego's significant transient population (military dependents who have moved from other states, seasonal workers from agricultural Imperial Valley) who haven't yet established California residency for Medi-Cal eligibility. California's 340B drug pricing: San Diego's Federally Qualified Health Centers (La Maestra Community Health Centers, San Ysidro Health, Family Health Centers of San Diego) are 340B-qualified — providing Clavam 625mg to their Medi-Cal and uninsured patients at 340B-reduced cost; patients who access these FQHC pharmacies receive the most affordable California access to Clavam. Clavam 625mg from Unnati Pharmax serves the population between Medi-Cal enrollment processing and active coverage, and San Diego's self-insured middle-income residents whose high-deductible California Exchange plans make antibiotic co-insurance significant.
FAQ 4: How does San Diego's biotech and pharma corridor workforce engage with Clavam 625mg?
San Diego's Torrey Pines Mesa and Sorrento Valley biotech corridor — home to more than 1,000 biotech and pharmaceutical companies including Illumina, Dexcom, Neurocrine Biosciences, and global operations of Johnson & Johnson, Pfizer, and Novartis R&D — employs approximately 70,000 life science workers. This sophisticated biomedical workforce has highly educated health engagement patterns that create specific Clavam 625mg dynamics. Biotech workforce pharmaceutical knowledge: San Diego's biotech scientists are among the most pharmacologically literate patients any physician encounters; they understand generic bioequivalence, WHO-GMP manufacturing standards, and clinical trial evidence — making the case for Clavam 625mg versus branded Co-Amoxiclav straightforward from a scientific credibility perspective; UCSD Health's primary care physicians note that San Diego biotech patients often arrive with already having researched their infection treatment options online. Occupational infection risks in San Diego's biotech labs: biosafety level 2 (BSL-2) laboratory exposures create theoretical infection risk — accidental mucosal exposure or needlestick injuries in biotech labs can transmit bacterial agents being studied; San Diego biotech companies maintain occupational health programmes (through UCSD's Occupational Medicine) that manage potential lab exposures including antibiotic prophylaxis where indicated. The comprehensive insurance advantage: San Diego's major biotech employers provide premium health insurance (Illumina, Dexcom, J&J offer Blue Shield, Anthem, or Kaiser plans with excellent drug benefits) — most biotech workforce Clavam prescriptions are covered with minimal co-payment. The Clavam 625mg from Unnati Pharmax demand from San Diego's biotech workforce is primarily during startup employment gaps (between pharmaceutical employer coverages), or for biotech professionals who want to understand and verify the quality of their medication supply from a scientific standard perspective.
Website
Email Id
Contact Number
+91-8265041513
Clavam-625mg-Co-Amoxiclav-San-Diego
